Pharma Industry News

A collection of Pharma latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.

bloomberg.com - Sun Pharma, Eli Lilly Lead Latest Rush of Healthcare M&A
Sun Pharma, Eli Lilly Lead Latest Rush of Healthcare M&A
Bloomberg

This article is for subscribers only. Hi, welcome to the Bloomberg Deals newsletter. We're starting the new week with a look at some big transactions spanning healthcare and oil and gas. Elsewhere, there's the latest on Hong Kong's largest equity…

forbes.com - Ian Sayson - Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
Indian Pharma Billionaire Dilip Shanghvi Doubles Down On The U.S. With $11.8 Billion Acquisition
Forbes

Sun Pharmaceutical Industries Ltd. signage is displayed outside the company's corporate office in Mumbai. © 2014 Bloomberg Finance LP Sun Pharmaceutical Industries—controlled by Indian billionaire Dilip Shanghvi —has agreed to…

yahoo.com - Usman Kabir - Ascendis Pharma A/S (ASND): Billionaire Joe Edelman Is Bullish on This Stock
Ascendis Pharma A/S (ASND): Billionaire Joe Edelman Is Bullish on This Stock
Yahoo!

We just covered the Billionaire Joe Edelman's 10 Stock Picks with Huge Upside Potential and Ascendis Pharma A/S (NASDAQ:ASND) ranks 9th on this list. The primary catalyst for hedge fund interest in Ascendis Pharma A/S (NASDAQ:ASND) stock over the…

independent.co.uk - Geoff Mulvihill - OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
The Independent

OxyContin maker Purdue Pharma could be dissolved and replaced by a company focused on the public good by the end of the week, as a massive legal settlement resolving thousands of lawsuits is set to take effect. A federal judge on Tuesday is…

bloomberg.com - Saikat Das - Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase
Sun Pharma Secures Bridge Loan for $12 Billion Organon Purchase
Bloomberg

Sun Pharmaceutical Industries Ltd. has lined up a short-term loan to help finance its $12 billion acquisition of New York-listed healthcare company Organon & Co., according to people familiar with the transaction. At least three banks —…

rediff.com - Nandita Malik - Sun Pharma's Dilip Shanghvi on Organon Acquisition: Debt, China Market & Biosimilars
Sun Pharma's Dilip Shanghvi on Organon Acquisition: Debt, China Market & Biosimilars
Rediff.com

Sun Pharmaceutical Industries' executive chairman Dilip Shanghvi shares his mixed feelings of happiness and anxiety regarding the company's $11.75 billion acquisition of US-based Organon & Co, a strategic move set to expand Sun Pharma's global…

winnipegfreepress.com - Geoff Mulvihill, The Associated Press - OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
OxyContin maker Purdue Pharma's criminal sentence could be the last step before company dissolves
Winnipeg Free Press

Email Address: I agree to the Terms and Conditions, Cookie and Privacy Policies, and CASL agreement. Already have an account? Log in here - To continue reading, please subscribe: Enjoy unlimited reading on winnipegfreepress.com Read the E-Edition…

cnbc.com - Angelica Peebles - Pharma bets a little-known type of cholesterol will underpin its next blockbuster heart drugs
Pharma bets a little-known type of cholesterol will underpin its next blockbuster heart drugs
CNBC

Novartis, Amgen and Eli Lilly are among the pharmaceutical companies developing drugs to lower levels of a particularly bad form of cholesterol called Lp(a) and potentially prevent heart attacks. Lp(a) levels are almost entirely genetically…

rediff.com - Nandita Malik - Indian Stock Markets Rebound: Sensex Jumps 639 Points, Nifty Up on Global Cues, Sun Pharma & RIL Rally
Indian Stock Markets Rebound: Sensex Jumps 639 Points, Nifty Up on Global Cues, Sun Pharma & RIL Rally
Rediff.com

Indian benchmark stock indices Sensex and Nifty staged a significant rebound, snapping a three-day losing streak, fuelled by strong performances from Reliance Industries and Sun Pharma, coupled with positive global market trends and easing…

rediff.com - Nandita Malik - Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Sun Pharma to Acquire Organon for $11.75 Billion, Expanding Global Footprint
Rediff.com

Sun Pharmaceutical Industries Ltd is set to acquire US-based Organon & Co for a staggering $11.75 billion, a strategic move poised to significantly expand its global footprint and elevate its standing among the world's top pharmaceutical companies.

bloomberg.com - Menaka Doshi - Sun Pharma Founder Says 'Debt-Averse, Not Risk-Averse' After $12 billion Organon Buy
Sun Pharma Founder Says 'Debt-Averse, Not Risk-Averse' After $12 billion Organon Buy
Bloomberg

Welcome to India Edition, Bloomberg's daily dive into what's moving the worlds of business, markets and politics in this dynamic, fast-paced economy. I'm Menaka Doshi. If you didn't receive this directly in your inbox, you can subscribe here, and…

pitcher.com - Dorota - Should You Trust AI Coaching for Pharma Reps?
Should You Trust AI Coaching for Pharma Reps?
AI Sales Enablement and Automation

AI coaching is no longer a side initiative for Pharma teams. Field leaders are under pressure to do more with smaller teams, tighter access to HCPs, and more digital-first calls. When every visit is short and closely monitored by compliance teams…

fool.com - Josh Kohn-Lindquist - Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
Stock Market Today, April 27: Organon Shares Surge After Sun Pharma Agrees to Acquire Company in All Cash Deal
The Motley Fool

Organon (OGN +16.87%), a women's health therapies specialist, closed Monday at $13.16, up 16.87%. The stock is jumping after premarket news that Sun Pharmaceutical Industries agreed to acquire Organon in an all-cash deal. Trading volume reached…

law360.com - Al Barbarino - US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal
US, Indian Firms Guide $11.75B Sun Pharma-Organon Deal
Law360

Indian pharmaceutical giant Sun Pharmaceutical Industries Ltd. has agreed to acquire New Jersey-based Organon & Co. in an all-cash deal valued at $11.75 billion, with each side of the transaction having representation... To view the full article…

thehindubusinessline.com - Sun Pharma-Organon deal: Outlook is mixed
Sun Pharma-Organon deal: Outlook is mixed
BusinessLine

Sun Pharma's agreement to acquire all outstanding shares of NYSE-listed Organon & Co for $14 per share in a cash deal, implies an enterprise value of $11.75 billion for Organon. This includes $3.99 billion in market cap and nearly $8-billion debt…

Receive a Daily briefing on Pharma Industry News

Get Started